April 29th 2025
A pre-clinical study shows the antibiotic, piperacillin, was effective at much lower dosages than doxycycline, and did so without disrupting the gut microbiome.
Canadian Health Agency Releases 2016 Report on Antibiotic-resistant Bacteria
September 19th 2016When the colistin-resistant gene, mcr-1, was first found in China in 2015, health officials around the world knew that the gene would inevitably appear in their countries. It has since been detected in other parts of Asia, Europe, and North America, including Canada, which just released a 2016 report from their Canadian Antimicrobial Resistance Surveillance System.
Read More
Federal Competition Seeks New Technology to Fight Antibiotic-Resistant Bacteria
September 19th 2016To find the next great innovation to fight the spread of drug-resistant bacteria, the National Institutes of Health has announced the launch of a new federal prize competition dubbed the Antimicrobial Resistance Diagnostic Challenge.
Read More
Developing New Antibiotics Can Control 'Superbug' Outbreaks
September 19th 2016Barry Kreiswirth, PhD, founding director, Public Health Research Institute Tuberculosis Center, professor of medicine at Rutgers University, discusses the alarming rate of which antibiotic-resistant strains and genes are spreading worldwide and our need for new, effective antibiotics to counteract it.
Watch
E. coli with Antibiotic-resistant mcr-1 Gene Found in Connecticut Child
September 13th 2016The CDC recently announced that their investigators have identified a strain of Escherichia coli with the colistin-resistance gene mcr-1 in a Connecticut child, in what is now the fourth patient in the United States to test positive for an isolate with mcr-1.
Read More
Identifying Pathogens for Targeted Therapy
September 10th 2016Kirk Hevener, PharmD, PhD, assistant professor of Biomedical and Pharmaceutical Sciences at Idaho State University, College of Pharmacy, explains how clinicians can identify pathogenic organisms to determine which narrow spectrum antibiotic to use for treatment.
Watch
New Genetic Research Holds Promise for C. Difficile Treatment
August 25th 2016In the battle against drug-resistant pathogens, genetic research holds promising answers to our toughest threats. A new study shows that the best tool for treating Clostridium difficile infections could be within the genome of the bacteria itself.
Read More
Pharmacists & Veterinarians Partner Up to Oversee Antibiotic Use in Agriculture
August 24th 2016Emily Heil, PharmD, BCPS-AQ ID, assistant professor at the University of Maryland School of Pharmacy, discusses how a new partnership between pharmacists and veterinarians will impact antimicrobial resistance.
Watch
Probiotics Could Offer Important Line of Defense Against Drug-resistant Bacteria
August 23rd 2016As the rise of antibiotic-resistant bacteria leads to higher rates of life-threatening infections from pathogens such Clostridium difficile and methicillin-resistant Staphylococcus aureus (MRSA), researchers are increasingly looking to probiotic treatment as an important part of fighting infections.
Read More
Reducing Antibiotic Use for Growth Promotion Purposes
August 19th 2016Emily Heil, PharmD, BCPS-AQ ID, assistant professor at the University of Maryland School of Pharmacy, explains how the FDA Guidance 213 and the Veterinary Feed Directive will change the use of antibiotics for growth promotion purposes in the United States.
Watch
Rapid CRP tests reduce antibiotic misuse & development of antibiotic resistance
August 5th 2016Researchers from the Oxford University Clinical Research Unit have found that a 5-minute CRP test can assist in the ongoing fight against antibiotic resistance by reducing antibiotic misuse for respiratory infections.
Read More
Key Risk Factors for Patient-to-Patient Transmission of Drug-Resistant Bacterium
August 1st 2016In a recent study, researchers identified three key factors that increase the risk for patient-to-patient transmission of carbapenemase-producing carbapenem-resistant Enterobacteriacecae (CP-CRE).
Read More
Shorter Antibiotic Regimens Recommended for Treatment of Pneumonia
August 1st 2016The IDSA and ATS have updated the Clinical Practice Guidelines for HAP & VAP for the first time since 2005 to recommend that each hospital generate antibiograms and reduce the use of antibiotics in treatment regiments.
Read More